Gaston Bauer Lecture: The renaissance of primary aldosteronism: what has it taught us
Michael is Director of the Hypertension Units, and Co-Director of the Endocrine Hypertension Research Centre (EHRC), at Greenslopes and Princess Alexandra Hospitals, University of Queensland School of Medicine, Brisbane, Australia.
Michael has over 20 years of clinical research experience in pathogenesis and management of hypertension and especially of endocrine varieties including primary aldosteronism (PA). Major areas of ongoing research include elucidating genetic bases for PA, determining the extent to which aldosterone excess in humans is capable of causing cardiovascular and other organ dysfunction independently of its effects on blood pressure, validating a new highly accurate method of measuring aldosterone using tandem mass spectrometry and improving methods of detection, diagnostic workup and management of PA.
Michael has served as Executive Committee Member of the High Blood Pressure Research Council of Australia (1998-2004; Secretary 2001-2004), member of the National Heart Foundation High Blood Pressure and Vascular Disease Advisory Committee (1998-) and organising committee member (including convenor) on several medical conferences. He is currently a member of the editorial board for the Journal of Clinical Endocrinology and Metabolism and Associate Editor for the Journal of Human Hypertension.